Nachrichten zur ASTRAZENECA DL-,25 SP.ADR Aktie

3 Magnificent Growth Stocks to Buy Right Now

In a sense, every investor is a growth investor. Even those who are primarily seeking income enjoy when the stocks…

AstraZeneca receives A1 rating upgrade from Moodys, outlook stable By Investing.com

AstraZeneca receives A1 rating upgrade from Moodys, outlook stable…

AstraZeneca Rises Almost 9% in a Month: How to Play the Stock

AZNs key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Fasenra are likely to drive sales in 2025.…

FTSE 100 dips as heavyweight ex-dividends drag, Lloyds soars

The FTSE 100 dropped again on Thursday as companies accounting for a significant proportion of the index traded ex-dividend and…

4 AI Stocks to Watch in the Quantum Computing Revolution

Following the stock markets record-breaking 2024, during which the S&P 500 index returned a spectacular 23%, theres optimism among investors…

Directorate Change

18 February 2025 Non-Executive Board Changes AstraZeneca PLC announced today that Karen Knudsen will be proposed for election as a Non-Executive Director…

AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally…

AZN IMPORTANT DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm – AZN

NEW YORK, Feb. 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025

Vertex Pharmaceuticals (NASDAQ: VRTX) and AstraZeneca (NASDAQ: AZN), two of the worlds leading drugmakers, missed last years strong market rally.…

AstraZeneca reports positive results for Imfinzi MIBC regimen

…

Could IonQ Stock Help You Retire a Millionaire?

The hot field of artificial intelligence (AI) helped the stock market reach new highs in 2024. Quantum computing is another…

Morgan Stanley sets AstraZeneca stock Overweight with £145 target By Investing.com

Morgan Stanley sets AstraZeneca stock Overweight with £145 target…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against IIPR, AstraZeneca, FTAI, and Revance and Encourages Investors to Contact the Firm

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm – AZN

NEW YORK, Feb. 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Shareholders that lost money on AstraZeneca PLC(AZN) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC ("AstraZeneca"…

FTSE 100 Live: Index slips from record; House prices hit record; L&G surges

FTSE 100 down 18 points L&G surges on Meji Yasuda deal House prices hit record in January 8.09am: FTSE 100…

Why AstraZeneca Topped the Market on Thursday

A fresh earnings release was the news development powering AstraZenecas (NASDAQ: AZN) share price higher on Thursday. Investors were clearly…

AstraZeneca Plc (AZN) Q4 2024 Earnings Call Transcript

AZN earnings call for the period ending December 31, 2024.…

AZN Q4 Earnings Lag, Sales Beat, Stock Up on China Probe Update

AstraZeneca reports mixed results in the fourth quarter. It gains in pre-market after assuring investors that the business impact of…

Astrazeneca will hohes Wachstumstempo dank neuer Medikamente auch 2025 halten

CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca hat sich dank eines überraschend starken Schlussspurts im vergangenen Jahr besser geschlagen als…

AstraZeneca beats Q4 top-line and bottom-line estimates; initiates FY25 outlook

…

FTSE 100 Live: Bank of England expected to cut interest rates

AstraZeneca and Watches of Switzerland will be in focus ahead of the Bank of Englands rate decision on Thursday. AstraZeneca…

FTSE 100 trounces record after Bank of England cuts interest

FTSE 100 jumps 117 points, sets record at 8,767 BoE cuts interest by 0.25% to 4.50% AstraZeneca surges on earnings beat 4.07pm: FTSE…

FTSE 100 Live: Index passes 8,700 for new record; Bank of England set to cut interest

FTSE 100 jumps 113 points, sets record at 8,736 BoE expected to cut interest AstraZeneca surges on earnings beat 10.50am: BoE expected…

FTSE 100 Live: Index notches new record; Bank of England set to cut interest

FTSE 100 jumps 67 points, sets record at 8,695 BoE expected to cut interest AstraZeneca among risers on update 8.33am: Compass…

FTSE 100 Live: Index receds from record after Bank of England cuts interest

FTSE 100 jumps 122 points, sets record at 8,767 BoE cuts interest by 0.25% to 4.50% AstraZeneca surges on earnings beat 3.01pm:…

FTSE 100 Live: Index smashes record as Bank of England cuts interest

FTSE 100 jumps 131 points, sets record at 8,767 BoE cuts interest by 0.25% to 4.50% AstraZeneca surges on earnings beat 2.14pm:…

FTSE 100 Live: Stocks trounce record as Bank of England cuts interest

FTSE 100 jumps 132 points, sets record at 8,755 BoE expected to cut interest AstraZeneca surges on earnings beat 12.11pm: Bank of…

FTSE 100 Live: Index tops 8,700 for first time; Bank of England set to cut interest

FTSE 100 jumps 87 points, sets record at 8,710 BoE expected to cut interest AstraZeneca surges on earnings beat 8.43am: FTSE 100…

Bank of England, AstraZeneca, Watches of Switzerland: Thursday ahead

AstraZeneca and Watches of Switzerland will be in focus ahead of the Bank of Englands rate decision on Thursday. AstraZeneca…

Lowey Dannenberg Notifies AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress…

CHMP Gives Nod to Expanded Use of J&Js Rybrevant & AZNs Imfinzi

The CHMP recommends approval for JNJs subcutaneous formulation of Rybrevant in NSCLC and AstraZenecas Imfinzi in limited-stage small-cell lung cancer.…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioAge, AstraZeneca, FTAI, and Revance and Encourages Investors to Contact the Firm

NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Total Voting Rights

3 February 2025 Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…

Imfinzi recommended for EU approval for LS-SCLC

3 February 2025 Imfinzi recommended for approval in the EU by CHMP as first and only immunotherapy for limited-stage small cell lung…

AstraZeneca ditches £450m investment in UK plant

The drugs giant blames "protracted" talks with the government as well as differences over funding.…

Vodafone, AstraZeneca, Amazon and Santander in busy week ahead

Vodafone, Santander, GSK, AstraZeneca and Diageo are among those teeing up a busy week ahead. Vodafone, as its £15 billion merger…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AstraZeneca, IIPR, Block, and Crocs and Encourages Investors to Contact the Firm

NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Enhertu approved in US for breast cancer post ET

28 January 2025 Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following…

FDA Expands Label of AZNs Enhertu for New Breast Cancer Indication

The FDA approves AstraZenecas sBLA for Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer in the United States.…

AstraZenecas Enhertu gets additional FDA approval

…

This Is the Most Promising Quantum Computing Stock, but Should You Buy It Right Now?

Quantum computing has the potential to accelerate how companies and scientists process data, which could lead to more advanced artificial…

Lowey Dannenberg Notifies AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress…

AstraZeneca to invest $570m in Canada, creating 700 new jobs By Investing.com

AstraZeneca to invest $570m in Canada, creating 700 new jobs…

AstraZenecas Growth Potential: 6 Reasons For A Buy Rating

…

AstraZeneca (AZN) Reels from China Investigation and Investor Suit– Hagens Berman

SAN FRANCISCO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- AstraZeneca (NASDAQ: AZN), the Anglo-Swedish pharmaceutical giant, has seen its…

InnovationRx: The Impact Of Trump’s Withdrawal From The WHO And His Other Healthcare Orders

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA approved.…

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

ASTRAZENECA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against AstraZeneca PLC and Encourages Investors to Contact the Firm

NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

Is Quantum Computing Leader IonQ Still a Buy After Falling 20%?

Quantum computing stocks landed on investors radars late last year when Alphabet announced a huge breakthrough with one of its…